GSTM1 and anemia: Recent data suggest that intravenous iron administration is safe, well tolerated and efficient particularly when it comes to patients with severe anemia (Hb < 10.0 g/dl), intolerant or non-responding to oral iron supplementation, and those with active disease (9).